Patient perspectives on whole-genome sequencing for undiagnosed diseases

被引:8
作者
Boeldt, Debra L. [1 ]
Cheung, Cynthia [2 ]
Ariniello, Lauren [1 ]
Darst, Burcu F. [1 ]
Topol, Sarah [1 ]
Schork, Nicholas J. [1 ,3 ]
Philis-Tsimikas, Athena [4 ]
Torkamani, Ali [1 ,5 ]
Fortmann, Addie L. [4 ]
Bloss, Cinnamon S. [1 ,6 ]
机构
[1] Scripps Hlth, Scripps Genom Med, Scripps Translat Sci Inst, La Jolla, CA USA
[2] Univ Calif San Diego, Qualcomm Inst Calit2, San Diego, CA 92103 USA
[3] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[4] Scripps Whittier Diabet Inst, La Jolla, CA USA
[5] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA
[6] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA
关键词
clinical sequencing; genetic testing; patient perceptions; precision medicine; qualitative data; rare diseases; undiagnosed diseases; whole-genome sequencing; INCIDENTAL FINDINGS; CLINICAL EXOME; RESEARCH PARTICIPANTS; ACMG RECOMMENDATIONS; MENDELIAN DISORDERS; AFRICAN-AMERICANS; RETURN; PROGRAM; ATTITUDES; AUTONOMY;
D O I
10.2217/pme-2016-0050
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study assessed perspectives on whole-genome sequencing (WGS) for rare disease diagnosis and the process of receiving genetic results. Semistructured interviews were conducted with adult patients and parents of minor patients affected by idiopathic diseases (n = 10 cases). Three main themes were identified through qualitative data analysis and interpretation: perceived benefits of WGS; perceived drawbacks of WGS; and perceptions of the return of results from WGS. Findings suggest that patients and their families have important perspectives on the use of WGS in diagnostic odyssey cases. These perspectives could inform clinical sequencing research study designs as well as the appropriate deployment of patient and family support services in the context of clinical genome sequencing.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 50 条
[21]   How should whole-genome sequencing be implemented in children? A consideration of the current limitations [J].
Char, Danton S. .
PERSONALIZED MEDICINE, 2016, 13 (01) :33-42
[22]   Editorial: Whole Genome Sequencing for rare diseases [J].
Di Resta, Chiara ;
D'Argenio, Valeria .
FRONTIERS IN MEDICINE, 2023, 10
[23]   Shared decision making: Implications for return of results from whole-exome and whole-genome sequencing [J].
Vadaparampil, Susan T. ;
Cragun, Deborah .
TRANSLATIONAL BEHAVIORAL MEDICINE, 2018, 8 (01) :80-84
[24]   The implications of whole-genome sequencing in the control of tuberculosis [J].
Lee, Robyn S. ;
Behr, Marcel A. .
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2016, 3 (02) :47-62
[25]   Parents' interest in whole-genome sequencing of newborns [J].
Goldenberg, Aaron J. ;
Dodson, Daniel S. ;
Davis, Matthew M. ;
Tarini, Beth A. .
GENETICS IN MEDICINE, 2014, 16 (01) :78-84
[26]   Whole-genome sequencing to control antimicrobial resistance [J].
Koeser, Claudio U. ;
Ellington, Matthew J. ;
Peacock, Sharon J. .
TRENDS IN GENETICS, 2014, 30 (09) :401-407
[27]   Opportunities and challenges of whole-genome and -exome sequencing [J].
Petersen, Britt-Sabina ;
Fredrich, Broder ;
Hoeppner, Marc P. ;
Ellinghaus, David ;
Franke, Andre .
BMC GENETICS, 2017, 18
[28]   Clinical whole-genome sequencing in cancer diagnosis [J].
Hou, Ying-Chen C. ;
Neidich, Julie A. ;
Duncavage, Eric J. ;
Spencer, David H. ;
Schroeder, Molly C. .
HUMAN MUTATION, 2022, 43 (11) :1519-1530
[29]   Opportunities and challenges of whole-genome and -exome sequencing [J].
Britt-Sabina Petersen ;
Broder Fredrich ;
Marc P. Hoeppner ;
David Ellinghaus ;
Andre Franke .
BMC Genetics, 18
[30]   Pediatric cancer families' participation in whole-genome sequencing research in Denmark: Parent perspectives [J].
Byrjalsen, Anna ;
Stoltze, Ulrik ;
Wadt, Karin ;
Hjalgrim, Lisa Lyngsie ;
Gerdes, Anne-Marie ;
Schmiegelow, Kjeld ;
Wahlberg, Ayo .
EUROPEAN JOURNAL OF CANCER CARE, 2018, 27 (06)